Tweenvest Stocks

Envoy Medical, Inc. (NasdaqCM: COCH)

Health Care · Health Care Equipment & Supplies · US

$0.66

-2.98% today · -26.8% 1Y

Envoy Medical, Inc. (NasdaqCM: COCH) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $50.78M and employs 43 people.

Over the last twelve months the share price has lost 26.8%, trading between 0.36 and 1.02.

Tweenvest scores Envoy Medical, Inc. across four factors: quality 33/100, value 43/100. Its strongest factor is value.

COCH price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$50.78M
Revenue (TTM)
$207.00K
P/E
—
EPS
-0.51
Dividend yield
—
Beta (5Y)
1.95
52-week high
$1.02
52-week low
$0.36
Avg volume (3M)
—
Shares outstanding
77.19M
Employees
43
Next earnings
—

About Envoy Medical, Inc.

Envoy Medical, Inc. is a healthcare company dedicated to developing innovative medical technologies that address the full spectrum of hearing loss. Its diverse product portfolio includes conventional hearing aids, Esteem middle ear implants, bone conduction devices, and Acclaim cochlear implants. Established in 1995, the company originally operated as St. Croix Medical, Inc. before officially rebranding to Envoy Medical, Inc. in December 2004. Envoy Medical, Inc. is headquartered in White Bear Lake, Minnesota.

ISIN
US29415V1098
Founded
1995
Listed since
Apr 29, 2021
Exchange
Nasdaq Capital Market
Currency
USD
CompanyMarket capPriceDay
Sugentech Inc.KOSDAQ: A253840$51.69M₩4,545.00-1.20%
Odysight.ai Inc.NasdaqCM: ODYS$51.62M$2.55-9.25%
Vaso CorporationOTCPK: VASO$51.49M$0.29-2.47%
Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim SirketiIBSE: ONCSM$51.28MTL106.10+10.52%
Precision Optics Corporation, Inc.NasdaqCM: POCI$50.26M$4.58-1.82%
TELA Bio, Inc.NasdaqGM: TELA$50.11M$1.11-2.63%
P&S Robotics Co., Ltd.KOSDAQ: A460940$50.04M₩5,000.00-5.30%
SELVAS Healthcare, Inc.KOSDAQ: A208370$49.83M₩2,605.00-2.07%

Browse every Health Care Equipment & Supplies company →

Figures last refreshed Oct 11, 2026.